nodes	percent_of_prediction	percent_of_DWPC	metapath
Doxazosin—CYP2C19—coronary artery disease	0.182	1	CbGaD
Doxazosin—ORM1—Penbutolol—coronary artery disease	0.0647	0.134	CbGbCtD
Doxazosin—ORM1—Pitavastatin—coronary artery disease	0.0566	0.117	CbGbCtD
Doxazosin—ABCB1—Ticagrelor—coronary artery disease	0.0231	0.0476	CbGbCtD
Doxazosin—CYP2C19—Gemfibrozil—coronary artery disease	0.0204	0.042	CbGbCtD
Doxazosin—CYP2C19—Clopidogrel—coronary artery disease	0.0176	0.0365	CbGbCtD
Doxazosin—CYP2C19—Telmisartan—coronary artery disease	0.0154	0.0319	CbGbCtD
Doxazosin—KCNH2—purkinje fiber—coronary artery disease	0.0153	0.516	CbGeAlD
Doxazosin—ABCB1—Perindopril—coronary artery disease	0.0142	0.0294	CbGbCtD
Doxazosin—ABCB1—Clopidogrel—coronary artery disease	0.0142	0.0294	CbGbCtD
Doxazosin—ABCB1—Pitavastatin—coronary artery disease	0.0124	0.0257	CbGbCtD
Doxazosin—ABCB1—Telmisartan—coronary artery disease	0.0124	0.0257	CbGbCtD
Doxazosin—CYP2C19—Timolol—coronary artery disease	0.0124	0.0257	CbGbCtD
Doxazosin—ABCB1—Enalapril—coronary artery disease	0.0118	0.0244	CbGbCtD
Doxazosin—ABCB1—Lisinopril—coronary artery disease	0.0118	0.0244	CbGbCtD
Doxazosin—CYP2C19—Rosuvastatin—coronary artery disease	0.0114	0.0235	CbGbCtD
Doxazosin—CYP2C19—Acetylsalicylic acid—coronary artery disease	0.0111	0.0229	CbGbCtD
Doxazosin—CYP2C19—Simvastatin—coronary artery disease	0.0106	0.0218	CbGbCtD
Doxazosin—CYP2C19—Lovastatin—coronary artery disease	0.0103	0.0214	CbGbCtD
Doxazosin—CYP2D6—Niacin—coronary artery disease	0.0102	0.021	CbGbCtD
Doxazosin—ABCB1—Timolol—coronary artery disease	0.01	0.0207	CbGbCtD
Doxazosin—CYP2D6—Timolol—coronary artery disease	0.00945	0.0195	CbGbCtD
Doxazosin—CYP2C19—Atorvastatin—coronary artery disease	0.00942	0.0195	CbGbCtD
Doxazosin—ABCB1—Ezetimibe—coronary artery disease	0.00918	0.019	CbGbCtD
Doxazosin—ABCB1—Acetylsalicylic acid—coronary artery disease	0.00894	0.0185	CbGbCtD
Doxazosin—ABCB1—Captopril—coronary artery disease	0.00883	0.0182	CbGbCtD
Doxazosin—CYP2C19—Losartan—coronary artery disease	0.00862	0.0178	CbGbCtD
Doxazosin—ABCB1—Simvastatin—coronary artery disease	0.00853	0.0176	CbGbCtD
Doxazosin—ABCB1—Pravastatin—coronary artery disease	0.00835	0.0172	CbGbCtD
Doxazosin—ABCB1—Lovastatin—coronary artery disease	0.00835	0.0172	CbGbCtD
Doxazosin—CYP2D6—Captopril—coronary artery disease	0.00832	0.0172	CbGbCtD
Doxazosin—CYP2D6—Simvastatin—coronary artery disease	0.00804	0.0166	CbGbCtD
Doxazosin—KCNH2—endocardium—coronary artery disease	0.00788	0.266	CbGeAlD
Doxazosin—CYP2D6—Pravastatin—coronary artery disease	0.00787	0.0162	CbGbCtD
Doxazosin—CYP2D6—Lovastatin—coronary artery disease	0.00787	0.0162	CbGbCtD
Doxazosin—ABCB1—Atorvastatin—coronary artery disease	0.0076	0.0157	CbGbCtD
Doxazosin—CYP2D6—Atorvastatin—coronary artery disease	0.00716	0.0148	CbGbCtD
Doxazosin—ABCB1—Losartan—coronary artery disease	0.00695	0.0144	CbGbCtD
Doxazosin—Prazosin—SLC22A3—coronary artery disease	0.00103	0.682	CrCbGaD
Doxazosin—KCNH2—cardiac ventricle—coronary artery disease	0.000663	0.0224	CbGeAlD
Doxazosin—KCNH2—myocardium—coronary artery disease	0.000624	0.021	CbGeAlD
Doxazosin—ORM1—blood—coronary artery disease	0.000482	0.0163	CbGeAlD
Doxazosin—Donepezil—HTR2A—coronary artery disease	0.000482	0.318	CrCbGaD
Doxazosin—ADRA1A—heart—coronary artery disease	0.000451	0.0152	CbGeAlD
Doxazosin—KCNH2—heart—coronary artery disease	0.000435	0.0147	CbGeAlD
Doxazosin—ADRA1A—cardiovascular system—coronary artery disease	0.000425	0.0143	CbGeAlD
Doxazosin—KCNH2—cardiovascular system—coronary artery disease	0.000411	0.0139	CbGeAlD
Doxazosin—KCNH2—cardiac atrium—coronary artery disease	0.000372	0.0126	CbGeAlD
Doxazosin—ADRA2A—heart—coronary artery disease	0.000343	0.0116	CbGeAlD
Doxazosin—CYP2C19—blood—coronary artery disease	0.000341	0.0115	CbGeAlD
Doxazosin—ADRA1A—blood—coronary artery disease	0.000336	0.0113	CbGeAlD
Doxazosin—KCNH2—blood—coronary artery disease	0.000325	0.011	CbGeAlD
Doxazosin—ADRA2A—cardiac atrium—coronary artery disease	0.000293	0.00989	CbGeAlD
Doxazosin—ADRA2A—blood—coronary artery disease	0.000256	0.00863	CbGeAlD
Doxazosin—CYP2D6—blood—coronary artery disease	0.000198	0.00668	CbGeAlD
Doxazosin—ABCB1—heart—coronary artery disease	0.000191	0.00644	CbGeAlD
Doxazosin—ABCB1—cardiovascular system—coronary artery disease	0.00018	0.00608	CbGeAlD
Doxazosin—ABCB1—blood—coronary artery disease	0.000142	0.00481	CbGeAlD
Doxazosin—Body temperature increased—Captopril—coronary artery disease	4.66e-05	0.000212	CcSEcCtD
Doxazosin—Dizziness—Simvastatin—coronary artery disease	4.65e-05	0.000212	CcSEcCtD
Doxazosin—Rash—Ezetimibe—coronary artery disease	4.65e-05	0.000212	CcSEcCtD
Doxazosin—Dermatitis—Ezetimibe—coronary artery disease	4.65e-05	0.000212	CcSEcCtD
Doxazosin—Confusional state—Ramipril—coronary artery disease	4.65e-05	0.000212	CcSEcCtD
Doxazosin—Discomfort—Timolol—coronary artery disease	4.64e-05	0.000211	CcSEcCtD
Doxazosin—Asthenia—Niacin—coronary artery disease	4.63e-05	0.000211	CcSEcCtD
Doxazosin—Fatigue—Losartan—coronary artery disease	4.63e-05	0.000211	CcSEcCtD
Doxazosin—Headache—Ezetimibe—coronary artery disease	4.62e-05	0.00021	CcSEcCtD
Doxazosin—Malaise—Lisinopril—coronary artery disease	4.62e-05	0.00021	CcSEcCtD
Doxazosin—Oedema—Ramipril—coronary artery disease	4.61e-05	0.00021	CcSEcCtD
Doxazosin—Vertigo—Lisinopril—coronary artery disease	4.6e-05	0.00021	CcSEcCtD
Doxazosin—Dry mouth—Timolol—coronary artery disease	4.59e-05	0.000209	CcSEcCtD
Doxazosin—Constipation—Losartan—coronary artery disease	4.59e-05	0.000209	CcSEcCtD
Doxazosin—Pain—Losartan—coronary artery disease	4.59e-05	0.000209	CcSEcCtD
Doxazosin—Syncope—Lisinopril—coronary artery disease	4.59e-05	0.000209	CcSEcCtD
Doxazosin—Vomiting—Eplerenone—coronary artery disease	4.59e-05	0.000209	CcSEcCtD
Doxazosin—Feeling abnormal—Furosemide—coronary artery disease	4.59e-05	0.000209	CcSEcCtD
Doxazosin—Leukopenia—Lisinopril—coronary artery disease	4.58e-05	0.000209	CcSEcCtD
Doxazosin—Nausea—Fenofibrate—coronary artery disease	4.57e-05	0.000208	CcSEcCtD
Doxazosin—Pruritus—Niacin—coronary artery disease	4.57e-05	0.000208	CcSEcCtD
Doxazosin—Asthenia—Pravastatin—coronary artery disease	4.56e-05	0.000208	CcSEcCtD
Doxazosin—Gastrointestinal pain—Furosemide—coronary artery disease	4.55e-05	0.000207	CcSEcCtD
Doxazosin—Rash—Eplerenone—coronary artery disease	4.55e-05	0.000207	CcSEcCtD
Doxazosin—Urticaria—Perindopril—coronary artery disease	4.55e-05	0.000207	CcSEcCtD
Doxazosin—Hypersensitivity—Trandolapril—coronary artery disease	4.55e-05	0.000207	CcSEcCtD
Doxazosin—Dermatitis—Eplerenone—coronary artery disease	4.55e-05	0.000207	CcSEcCtD
Doxazosin—Diarrhoea—Valsartan—coronary artery disease	4.55e-05	0.000207	CcSEcCtD
Doxazosin—Confusional state—Timolol—coronary artery disease	4.54e-05	0.000207	CcSEcCtD
Doxazosin—Shock—Ramipril—coronary artery disease	4.53e-05	0.000206	CcSEcCtD
Doxazosin—Hypersensitivity—Enalapril—coronary artery disease	4.53e-05	0.000206	CcSEcCtD
Doxazosin—Body temperature increased—Perindopril—coronary artery disease	4.53e-05	0.000206	CcSEcCtD
Doxazosin—Abdominal pain—Perindopril—coronary artery disease	4.53e-05	0.000206	CcSEcCtD
Doxazosin—Palpitations—Lisinopril—coronary artery disease	4.52e-05	0.000206	CcSEcCtD
Doxazosin—Diarrhoea—Olmesartan—coronary artery disease	4.52e-05	0.000206	CcSEcCtD
Doxazosin—Headache—Eplerenone—coronary artery disease	4.52e-05	0.000206	CcSEcCtD
Doxazosin—Thrombocytopenia—Ramipril—coronary artery disease	4.51e-05	0.000205	CcSEcCtD
Doxazosin—Oedema—Timolol—coronary artery disease	4.5e-05	0.000205	CcSEcCtD
Doxazosin—Pruritus—Pravastatin—coronary artery disease	4.5e-05	0.000205	CcSEcCtD
Doxazosin—Loss of consciousness—Lisinopril—coronary artery disease	4.5e-05	0.000205	CcSEcCtD
Doxazosin—Nausea—Clopidogrel—coronary artery disease	4.5e-05	0.000205	CcSEcCtD
Doxazosin—Tachycardia—Ramipril—coronary artery disease	4.5e-05	0.000205	CcSEcCtD
Doxazosin—Skin disorder—Ramipril—coronary artery disease	4.47e-05	0.000204	CcSEcCtD
Doxazosin—Infection—Timolol—coronary artery disease	4.47e-05	0.000204	CcSEcCtD
Doxazosin—Vomiting—Simvastatin—coronary artery disease	4.47e-05	0.000204	CcSEcCtD
Doxazosin—Hypersensitivity—Telmisartan—coronary artery disease	4.47e-05	0.000204	CcSEcCtD
Doxazosin—Cough—Lisinopril—coronary artery disease	4.47e-05	0.000203	CcSEcCtD
Doxazosin—Nausea—Lovastatin—coronary artery disease	4.47e-05	0.000203	CcSEcCtD
Doxazosin—Hyperhidrosis—Ramipril—coronary artery disease	4.45e-05	0.000203	CcSEcCtD
Doxazosin—Rash—Simvastatin—coronary artery disease	4.44e-05	0.000202	CcSEcCtD
Doxazosin—Dermatitis—Simvastatin—coronary artery disease	4.43e-05	0.000202	CcSEcCtD
Doxazosin—Asthenia—Trandolapril—coronary artery disease	4.43e-05	0.000202	CcSEcCtD
Doxazosin—Shock—Timolol—coronary artery disease	4.43e-05	0.000202	CcSEcCtD
Doxazosin—Feeling abnormal—Losartan—coronary artery disease	4.43e-05	0.000202	CcSEcCtD
Doxazosin—Urticaria—Furosemide—coronary artery disease	4.42e-05	0.000201	CcSEcCtD
Doxazosin—Diarrhoea—Niacin—coronary artery disease	4.42e-05	0.000201	CcSEcCtD
Doxazosin—Asthenia—Enalapril—coronary artery disease	4.41e-05	0.000201	CcSEcCtD
Doxazosin—Headache—Simvastatin—coronary artery disease	4.41e-05	0.000201	CcSEcCtD
Doxazosin—Body temperature increased—Furosemide—coronary artery disease	4.4e-05	0.000201	CcSEcCtD
Doxazosin—Abdominal pain—Furosemide—coronary artery disease	4.4e-05	0.000201	CcSEcCtD
Doxazosin—Gastrointestinal pain—Losartan—coronary artery disease	4.39e-05	0.0002	CcSEcCtD
Doxazosin—Dizziness—Valsartan—coronary artery disease	4.39e-05	0.0002	CcSEcCtD
Doxazosin—Anorexia—Ramipril—coronary artery disease	4.39e-05	0.0002	CcSEcCtD
Doxazosin—Nausea—Ezetimibe—coronary artery disease	4.38e-05	0.0002	CcSEcCtD
Doxazosin—Skin disorder—Timolol—coronary artery disease	4.37e-05	0.000199	CcSEcCtD
Doxazosin—Dizziness—Olmesartan—coronary artery disease	4.37e-05	0.000199	CcSEcCtD
Doxazosin—Pruritus—Trandolapril—coronary artery disease	4.37e-05	0.000199	CcSEcCtD
Doxazosin—Myalgia—Lisinopril—coronary artery disease	4.36e-05	0.000199	CcSEcCtD
Doxazosin—Chest pain—Lisinopril—coronary artery disease	4.36e-05	0.000199	CcSEcCtD
Doxazosin—Arthralgia—Lisinopril—coronary artery disease	4.36e-05	0.000199	CcSEcCtD
Doxazosin—Hyperhidrosis—Timolol—coronary artery disease	4.35e-05	0.000198	CcSEcCtD
Doxazosin—Asthenia—Telmisartan—coronary artery disease	4.35e-05	0.000198	CcSEcCtD
Doxazosin—Pruritus—Enalapril—coronary artery disease	4.35e-05	0.000198	CcSEcCtD
Doxazosin—Diarrhoea—Pravastatin—coronary artery disease	4.35e-05	0.000198	CcSEcCtD
Doxazosin—Anxiety—Lisinopril—coronary artery disease	4.34e-05	0.000198	CcSEcCtD
Doxazosin—Discomfort—Lisinopril—coronary artery disease	4.31e-05	0.000196	CcSEcCtD
Doxazosin—Hypotension—Ramipril—coronary artery disease	4.3e-05	0.000196	CcSEcCtD
Doxazosin—Anorexia—Timolol—coronary artery disease	4.29e-05	0.000196	CcSEcCtD
Doxazosin—Pruritus—Telmisartan—coronary artery disease	4.29e-05	0.000196	CcSEcCtD
Doxazosin—Nausea—Eplerenone—coronary artery disease	4.29e-05	0.000195	CcSEcCtD
Doxazosin—Dizziness—Niacin—coronary artery disease	4.27e-05	0.000195	CcSEcCtD
Doxazosin—Urticaria—Losartan—coronary artery disease	4.27e-05	0.000194	CcSEcCtD
Doxazosin—Dry mouth—Lisinopril—coronary artery disease	4.26e-05	0.000194	CcSEcCtD
Doxazosin—Abdominal pain—Losartan—coronary artery disease	4.25e-05	0.000193	CcSEcCtD
Doxazosin—Body temperature increased—Losartan—coronary artery disease	4.25e-05	0.000193	CcSEcCtD
Doxazosin—Asthenia—Captopril—coronary artery disease	4.23e-05	0.000193	CcSEcCtD
Doxazosin—Diarrhoea—Trandolapril—coronary artery disease	4.23e-05	0.000192	CcSEcCtD
Doxazosin—Vomiting—Valsartan—coronary artery disease	4.22e-05	0.000192	CcSEcCtD
Doxazosin—Confusional state—Lisinopril—coronary artery disease	4.21e-05	0.000192	CcSEcCtD
Doxazosin—Diarrhoea—Enalapril—coronary artery disease	4.21e-05	0.000192	CcSEcCtD
Doxazosin—Hypotension—Timolol—coronary artery disease	4.21e-05	0.000192	CcSEcCtD
Doxazosin—Dizziness—Pravastatin—coronary artery disease	4.21e-05	0.000192	CcSEcCtD
Doxazosin—Vomiting—Olmesartan—coronary artery disease	4.2e-05	0.000191	CcSEcCtD
Doxazosin—Musculoskeletal discomfort—Ramipril—coronary artery disease	4.2e-05	0.000191	CcSEcCtD
Doxazosin—Rash—Valsartan—coronary artery disease	4.19e-05	0.000191	CcSEcCtD
Doxazosin—Dermatitis—Valsartan—coronary artery disease	4.18e-05	0.000191	CcSEcCtD
Doxazosin—Nausea—Simvastatin—coronary artery disease	4.18e-05	0.00019	CcSEcCtD
Doxazosin—Oedema—Lisinopril—coronary artery disease	4.18e-05	0.00019	CcSEcCtD
Doxazosin—Pruritus—Captopril—coronary artery disease	4.17e-05	0.00019	CcSEcCtD
Doxazosin—Rash—Olmesartan—coronary artery disease	4.17e-05	0.00019	CcSEcCtD
Doxazosin—Insomnia—Ramipril—coronary artery disease	4.17e-05	0.00019	CcSEcCtD
Doxazosin—Dermatitis—Olmesartan—coronary artery disease	4.16e-05	0.00019	CcSEcCtD
Doxazosin—Headache—Valsartan—coronary artery disease	4.16e-05	0.00019	CcSEcCtD
Doxazosin—Diarrhoea—Telmisartan—coronary artery disease	4.15e-05	0.000189	CcSEcCtD
Doxazosin—Infection—Lisinopril—coronary artery disease	4.15e-05	0.000189	CcSEcCtD
Doxazosin—Headache—Olmesartan—coronary artery disease	4.14e-05	0.000189	CcSEcCtD
Doxazosin—Paraesthesia—Ramipril—coronary artery disease	4.14e-05	0.000188	CcSEcCtD
Doxazosin—Shock—Lisinopril—coronary artery disease	4.11e-05	0.000187	CcSEcCtD
Doxazosin—Asthenia—Perindopril—coronary artery disease	4.11e-05	0.000187	CcSEcCtD
Doxazosin—Dyspnoea—Ramipril—coronary artery disease	4.11e-05	0.000187	CcSEcCtD
Doxazosin—Vomiting—Niacin—coronary artery disease	4.11e-05	0.000187	CcSEcCtD
Doxazosin—Musculoskeletal discomfort—Timolol—coronary artery disease	4.1e-05	0.000187	CcSEcCtD
Doxazosin—Hypersensitivity—Furosemide—coronary artery disease	4.1e-05	0.000187	CcSEcCtD
Doxazosin—Somnolence—Ramipril—coronary artery disease	4.1e-05	0.000187	CcSEcCtD
Doxazosin—Thrombocytopenia—Lisinopril—coronary artery disease	4.09e-05	0.000186	CcSEcCtD
Doxazosin—Dizziness—Trandolapril—coronary artery disease	4.08e-05	0.000186	CcSEcCtD
Doxazosin—Tachycardia—Lisinopril—coronary artery disease	4.08e-05	0.000186	CcSEcCtD
Doxazosin—Insomnia—Timolol—coronary artery disease	4.07e-05	0.000186	CcSEcCtD
Doxazosin—Rash—Niacin—coronary artery disease	4.07e-05	0.000186	CcSEcCtD
Doxazosin—Dermatitis—Niacin—coronary artery disease	4.07e-05	0.000185	CcSEcCtD
Doxazosin—Dizziness—Enalapril—coronary artery disease	4.07e-05	0.000185	CcSEcCtD
Doxazosin—Skin disorder—Lisinopril—coronary artery disease	4.06e-05	0.000185	CcSEcCtD
Doxazosin—Dyspepsia—Ramipril—coronary artery disease	4.06e-05	0.000185	CcSEcCtD
Doxazosin—Pruritus—Perindopril—coronary artery disease	4.05e-05	0.000185	CcSEcCtD
Doxazosin—Headache—Niacin—coronary artery disease	4.05e-05	0.000184	CcSEcCtD
Doxazosin—Paraesthesia—Timolol—coronary artery disease	4.04e-05	0.000184	CcSEcCtD
Doxazosin—Vomiting—Pravastatin—coronary artery disease	4.04e-05	0.000184	CcSEcCtD
Doxazosin—Hyperhidrosis—Lisinopril—coronary artery disease	4.04e-05	0.000184	CcSEcCtD
Doxazosin—Diarrhoea—Captopril—coronary artery disease	4.04e-05	0.000184	CcSEcCtD
Doxazosin—Dyspnoea—Timolol—coronary artery disease	4.02e-05	0.000183	CcSEcCtD
Doxazosin—Dizziness—Telmisartan—coronary artery disease	4.01e-05	0.000183	CcSEcCtD
Doxazosin—Rash—Pravastatin—coronary artery disease	4.01e-05	0.000183	CcSEcCtD
Doxazosin—Dermatitis—Pravastatin—coronary artery disease	4.01e-05	0.000182	CcSEcCtD
Doxazosin—Decreased appetite—Ramipril—coronary artery disease	4e-05	0.000182	CcSEcCtD
Doxazosin—Somnolence—Timolol—coronary artery disease	4e-05	0.000182	CcSEcCtD
Doxazosin—Asthenia—Furosemide—coronary artery disease	4e-05	0.000182	CcSEcCtD
Doxazosin—Headache—Pravastatin—coronary artery disease	3.98e-05	0.000181	CcSEcCtD
Doxazosin—Anorexia—Lisinopril—coronary artery disease	3.98e-05	0.000181	CcSEcCtD
Doxazosin—Fatigue—Ramipril—coronary artery disease	3.97e-05	0.000181	CcSEcCtD
Doxazosin—Dyspepsia—Timolol—coronary artery disease	3.96e-05	0.000181	CcSEcCtD
Doxazosin—Hypersensitivity—Losartan—coronary artery disease	3.96e-05	0.00018	CcSEcCtD
Doxazosin—Nausea—Valsartan—coronary artery disease	3.95e-05	0.00018	CcSEcCtD
Doxazosin—Pruritus—Furosemide—coronary artery disease	3.94e-05	0.000179	CcSEcCtD
Doxazosin—Constipation—Ramipril—coronary artery disease	3.94e-05	0.000179	CcSEcCtD
Doxazosin—Nausea—Olmesartan—coronary artery disease	3.93e-05	0.000179	CcSEcCtD
Doxazosin—Vomiting—Trandolapril—coronary artery disease	3.93e-05	0.000179	CcSEcCtD
Doxazosin—Diarrhoea—Perindopril—coronary artery disease	3.92e-05	0.000179	CcSEcCtD
Doxazosin—Decreased appetite—Timolol—coronary artery disease	3.92e-05	0.000178	CcSEcCtD
Doxazosin—Vomiting—Enalapril—coronary artery disease	3.91e-05	0.000178	CcSEcCtD
Doxazosin—Hypotension—Lisinopril—coronary artery disease	3.9e-05	0.000178	CcSEcCtD
Doxazosin—Dizziness—Captopril—coronary artery disease	3.9e-05	0.000178	CcSEcCtD
Doxazosin—Rash—Trandolapril—coronary artery disease	3.89e-05	0.000177	CcSEcCtD
Doxazosin—Dermatitis—Trandolapril—coronary artery disease	3.89e-05	0.000177	CcSEcCtD
Doxazosin—Fatigue—Timolol—coronary artery disease	3.88e-05	0.000177	CcSEcCtD
Doxazosin—Rash—Enalapril—coronary artery disease	3.88e-05	0.000177	CcSEcCtD
Doxazosin—Dermatitis—Enalapril—coronary artery disease	3.87e-05	0.000176	CcSEcCtD
Doxazosin—Headache—Trandolapril—coronary artery disease	3.87e-05	0.000176	CcSEcCtD
Doxazosin—Vomiting—Telmisartan—coronary artery disease	3.86e-05	0.000176	CcSEcCtD
Doxazosin—Asthenia—Losartan—coronary artery disease	3.85e-05	0.000176	CcSEcCtD
Doxazosin—Headache—Enalapril—coronary artery disease	3.85e-05	0.000176	CcSEcCtD
Doxazosin—Pain—Timolol—coronary artery disease	3.85e-05	0.000175	CcSEcCtD
Doxazosin—Nausea—Niacin—coronary artery disease	3.84e-05	0.000175	CcSEcCtD
Doxazosin—Rash—Telmisartan—coronary artery disease	3.83e-05	0.000174	CcSEcCtD
Doxazosin—Dermatitis—Telmisartan—coronary artery disease	3.82e-05	0.000174	CcSEcCtD
Doxazosin—Diarrhoea—Furosemide—coronary artery disease	3.81e-05	0.000174	CcSEcCtD
Doxazosin—Musculoskeletal discomfort—Lisinopril—coronary artery disease	3.81e-05	0.000173	CcSEcCtD
Doxazosin—Pruritus—Losartan—coronary artery disease	3.8e-05	0.000173	CcSEcCtD
Doxazosin—Headache—Telmisartan—coronary artery disease	3.8e-05	0.000173	CcSEcCtD
Doxazosin—Feeling abnormal—Ramipril—coronary artery disease	3.8e-05	0.000173	CcSEcCtD
Doxazosin—Dizziness—Perindopril—coronary artery disease	3.79e-05	0.000173	CcSEcCtD
Doxazosin—Insomnia—Lisinopril—coronary artery disease	3.78e-05	0.000172	CcSEcCtD
Doxazosin—Nausea—Pravastatin—coronary artery disease	3.78e-05	0.000172	CcSEcCtD
Doxazosin—Gastrointestinal pain—Ramipril—coronary artery disease	3.77e-05	0.000172	CcSEcCtD
Doxazosin—Paraesthesia—Lisinopril—coronary artery disease	3.75e-05	0.000171	CcSEcCtD
Doxazosin—Vomiting—Captopril—coronary artery disease	3.75e-05	0.000171	CcSEcCtD
Doxazosin—Dyspnoea—Lisinopril—coronary artery disease	3.72e-05	0.00017	CcSEcCtD
Doxazosin—Rash—Captopril—coronary artery disease	3.72e-05	0.000169	CcSEcCtD
Doxazosin—Dermatitis—Captopril—coronary artery disease	3.72e-05	0.000169	CcSEcCtD
Doxazosin—Somnolence—Lisinopril—coronary artery disease	3.71e-05	0.000169	CcSEcCtD
Doxazosin—Feeling abnormal—Timolol—coronary artery disease	3.71e-05	0.000169	CcSEcCtD
Doxazosin—Headache—Captopril—coronary artery disease	3.7e-05	0.000168	CcSEcCtD
Doxazosin—Gastrointestinal pain—Timolol—coronary artery disease	3.68e-05	0.000168	CcSEcCtD
Doxazosin—Dizziness—Furosemide—coronary artery disease	3.68e-05	0.000168	CcSEcCtD
Doxazosin—Dyspepsia—Lisinopril—coronary artery disease	3.68e-05	0.000168	CcSEcCtD
Doxazosin—Diarrhoea—Losartan—coronary artery disease	3.68e-05	0.000167	CcSEcCtD
Doxazosin—Nausea—Trandolapril—coronary artery disease	3.67e-05	0.000167	CcSEcCtD
Doxazosin—Urticaria—Ramipril—coronary artery disease	3.66e-05	0.000167	CcSEcCtD
Doxazosin—Nausea—Enalapril—coronary artery disease	3.65e-05	0.000166	CcSEcCtD
Doxazosin—Vomiting—Perindopril—coronary artery disease	3.64e-05	0.000166	CcSEcCtD
Doxazosin—Body temperature increased—Ramipril—coronary artery disease	3.64e-05	0.000166	CcSEcCtD
Doxazosin—Abdominal pain—Ramipril—coronary artery disease	3.64e-05	0.000166	CcSEcCtD
Doxazosin—Decreased appetite—Lisinopril—coronary artery disease	3.63e-05	0.000165	CcSEcCtD
Doxazosin—Rash—Perindopril—coronary artery disease	3.61e-05	0.000165	CcSEcCtD
Doxazosin—Dermatitis—Perindopril—coronary artery disease	3.61e-05	0.000164	CcSEcCtD
Doxazosin—Nausea—Telmisartan—coronary artery disease	3.6e-05	0.000164	CcSEcCtD
Doxazosin—Fatigue—Lisinopril—coronary artery disease	3.6e-05	0.000164	CcSEcCtD
Doxazosin—Headache—Perindopril—coronary artery disease	3.59e-05	0.000163	CcSEcCtD
Doxazosin—Urticaria—Timolol—coronary artery disease	3.58e-05	0.000163	CcSEcCtD
Doxazosin—Constipation—Lisinopril—coronary artery disease	3.57e-05	0.000163	CcSEcCtD
Doxazosin—Pain—Lisinopril—coronary artery disease	3.57e-05	0.000163	CcSEcCtD
Doxazosin—Body temperature increased—Timolol—coronary artery disease	3.56e-05	0.000162	CcSEcCtD
Doxazosin—Abdominal pain—Timolol—coronary artery disease	3.56e-05	0.000162	CcSEcCtD
Doxazosin—Dizziness—Losartan—coronary artery disease	3.55e-05	0.000162	CcSEcCtD
Doxazosin—Vomiting—Furosemide—coronary artery disease	3.54e-05	0.000161	CcSEcCtD
Doxazosin—Rash—Furosemide—coronary artery disease	3.51e-05	0.00016	CcSEcCtD
Doxazosin—Dermatitis—Furosemide—coronary artery disease	3.51e-05	0.00016	CcSEcCtD
Doxazosin—Nausea—Captopril—coronary artery disease	3.5e-05	0.00016	CcSEcCtD
Doxazosin—Headache—Furosemide—coronary artery disease	3.49e-05	0.000159	CcSEcCtD
Doxazosin—Feeling abnormal—Lisinopril—coronary artery disease	3.44e-05	0.000157	CcSEcCtD
Doxazosin—Gastrointestinal pain—Lisinopril—coronary artery disease	3.42e-05	0.000156	CcSEcCtD
Doxazosin—Vomiting—Losartan—coronary artery disease	3.42e-05	0.000156	CcSEcCtD
Doxazosin—Nausea—Perindopril—coronary artery disease	3.4e-05	0.000155	CcSEcCtD
Doxazosin—Hypersensitivity—Ramipril—coronary artery disease	3.39e-05	0.000155	CcSEcCtD
Doxazosin—Rash—Losartan—coronary artery disease	3.39e-05	0.000154	CcSEcCtD
Doxazosin—Dermatitis—Losartan—coronary artery disease	3.38e-05	0.000154	CcSEcCtD
Doxazosin—Headache—Losartan—coronary artery disease	3.37e-05	0.000153	CcSEcCtD
Doxazosin—Urticaria—Lisinopril—coronary artery disease	3.32e-05	0.000151	CcSEcCtD
Doxazosin—Hypersensitivity—Timolol—coronary artery disease	3.32e-05	0.000151	CcSEcCtD
Doxazosin—Nausea—Furosemide—coronary artery disease	3.31e-05	0.000151	CcSEcCtD
Doxazosin—Asthenia—Ramipril—coronary artery disease	3.31e-05	0.000151	CcSEcCtD
Doxazosin—Body temperature increased—Lisinopril—coronary artery disease	3.3e-05	0.00015	CcSEcCtD
Doxazosin—Abdominal pain—Lisinopril—coronary artery disease	3.3e-05	0.00015	CcSEcCtD
Doxazosin—Pruritus—Ramipril—coronary artery disease	3.26e-05	0.000148	CcSEcCtD
Doxazosin—Asthenia—Timolol—coronary artery disease	3.23e-05	0.000147	CcSEcCtD
Doxazosin—Nausea—Losartan—coronary artery disease	3.19e-05	0.000145	CcSEcCtD
Doxazosin—Pruritus—Timolol—coronary artery disease	3.19e-05	0.000145	CcSEcCtD
Doxazosin—Diarrhoea—Ramipril—coronary artery disease	3.15e-05	0.000144	CcSEcCtD
Doxazosin—Diarrhoea—Timolol—coronary artery disease	3.08e-05	0.00014	CcSEcCtD
Doxazosin—Hypersensitivity—Lisinopril—coronary artery disease	3.08e-05	0.00014	CcSEcCtD
Doxazosin—Dizziness—Ramipril—coronary artery disease	3.05e-05	0.000139	CcSEcCtD
Doxazosin—Asthenia—Lisinopril—coronary artery disease	3e-05	0.000137	CcSEcCtD
Doxazosin—Dizziness—Timolol—coronary artery disease	2.98e-05	0.000136	CcSEcCtD
Doxazosin—Pruritus—Lisinopril—coronary artery disease	2.96e-05	0.000135	CcSEcCtD
Doxazosin—Vomiting—Ramipril—coronary artery disease	2.93e-05	0.000133	CcSEcCtD
Doxazosin—Rash—Ramipril—coronary artery disease	2.9e-05	0.000132	CcSEcCtD
Doxazosin—Dermatitis—Ramipril—coronary artery disease	2.9e-05	0.000132	CcSEcCtD
Doxazosin—Headache—Ramipril—coronary artery disease	2.89e-05	0.000131	CcSEcCtD
Doxazosin—Vomiting—Timolol—coronary artery disease	2.86e-05	0.00013	CcSEcCtD
Doxazosin—Diarrhoea—Lisinopril—coronary artery disease	2.86e-05	0.00013	CcSEcCtD
Doxazosin—Rash—Timolol—coronary artery disease	2.84e-05	0.000129	CcSEcCtD
Doxazosin—Dermatitis—Timolol—coronary artery disease	2.84e-05	0.000129	CcSEcCtD
Doxazosin—Headache—Timolol—coronary artery disease	2.82e-05	0.000129	CcSEcCtD
Doxazosin—Dizziness—Lisinopril—coronary artery disease	2.76e-05	0.000126	CcSEcCtD
Doxazosin—Nausea—Ramipril—coronary artery disease	2.74e-05	0.000125	CcSEcCtD
Doxazosin—Nausea—Timolol—coronary artery disease	2.68e-05	0.000122	CcSEcCtD
Doxazosin—Vomiting—Lisinopril—coronary artery disease	2.66e-05	0.000121	CcSEcCtD
Doxazosin—Rash—Lisinopril—coronary artery disease	2.63e-05	0.00012	CcSEcCtD
Doxazosin—Dermatitis—Lisinopril—coronary artery disease	2.63e-05	0.00012	CcSEcCtD
Doxazosin—Headache—Lisinopril—coronary artery disease	2.62e-05	0.000119	CcSEcCtD
Doxazosin—Nausea—Lisinopril—coronary artery disease	2.48e-05	0.000113	CcSEcCtD
Doxazosin—ADRA1D—Signaling Pathways—GSK3B—coronary artery disease	3.85e-06	4.62e-05	CbGpPWpGaD
Doxazosin—ABCB1—Metabolism—ABCA1—coronary artery disease	3.83e-06	4.59e-05	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—POMC—coronary artery disease	3.82e-06	4.58e-05	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—CREB1—coronary artery disease	3.82e-06	4.58e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—APOB—coronary artery disease	3.8e-06	4.56e-05	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism—GGT1—coronary artery disease	3.8e-06	4.55e-05	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism—GOT1—coronary artery disease	3.8e-06	4.55e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Hemostasis—PIK3CA—coronary artery disease	3.78e-06	4.54e-05	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—HIF1A—coronary artery disease	3.78e-06	4.53e-05	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—ITGB3—coronary artery disease	3.77e-06	4.53e-05	CbGpPWpGaD
Doxazosin—ADRA2A—GPCR downstream signaling—CXCL8—coronary artery disease	3.77e-06	4.52e-05	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—AGT—coronary artery disease	3.76e-06	4.51e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling by GPCR—JAK2—coronary artery disease	3.75e-06	4.5e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—EDN1—coronary artery disease	3.74e-06	4.49e-05	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—CCL2—coronary artery disease	3.73e-06	4.48e-05	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—IL6R—coronary artery disease	3.72e-06	4.47e-05	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—PLCB1—coronary artery disease	3.72e-06	4.46e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Metabolism—AGT—coronary artery disease	3.71e-06	4.46e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—CCL5—coronary artery disease	3.71e-06	4.45e-05	CbGpPWpGaD
Doxazosin—ABCB1—Metabolism—GOT1—coronary artery disease	3.7e-06	4.45e-05	CbGpPWpGaD
Doxazosin—ABCB1—Metabolism—GGT1—coronary artery disease	3.7e-06	4.45e-05	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—APOE—coronary artery disease	3.69e-06	4.42e-05	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—LEP—coronary artery disease	3.69e-06	4.42e-05	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling by GPCR—CXCL8—coronary artery disease	3.68e-06	4.42e-05	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—IGF1—coronary artery disease	3.67e-06	4.4e-05	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—PPP2CA—coronary artery disease	3.67e-06	4.4e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—CSF2—coronary artery disease	3.66e-06	4.39e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—FGF1—coronary artery disease	3.66e-06	4.39e-05	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling by GPCR—MAPK1—coronary artery disease	3.65e-06	4.38e-05	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—APOA1—coronary artery disease	3.64e-06	4.37e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Metabolism—APOE—coronary artery disease	3.64e-06	4.37e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—LPL—coronary artery disease	3.63e-06	4.36e-05	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—KDR—coronary artery disease	3.61e-06	4.33e-05	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—ABCA1—coronary artery disease	3.6e-06	4.33e-05	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—PRKCD—coronary artery disease	3.6e-06	4.32e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—RPS6KB1—coronary artery disease	3.6e-06	4.32e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—MEF2C—coronary artery disease	3.6e-06	4.32e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Metabolism—APOA1—coronary artery disease	3.6e-06	4.32e-05	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—MAPK14—coronary artery disease	3.59e-06	4.31e-05	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—HTR2A—coronary artery disease	3.52e-06	4.23e-05	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—ESR1—coronary artery disease	3.52e-06	4.22e-05	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—C3—coronary artery disease	3.52e-06	4.22e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—ITGB3—coronary artery disease	3.51e-06	4.21e-05	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—GGT1—coronary artery disease	3.49e-06	4.19e-05	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—GOT1—coronary artery disease	3.49e-06	4.19e-05	CbGpPWpGaD
Doxazosin—ADRA1D—GPCR downstream signaling—PIK3CA—coronary artery disease	3.49e-06	4.19e-05	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—SERPINE1—coronary artery disease	3.49e-06	4.18e-05	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—FN1—coronary artery disease	3.48e-06	4.17e-05	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—F2—coronary artery disease	3.48e-06	4.17e-05	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—IL6ST—coronary artery disease	3.46e-06	4.16e-05	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—NFKBIA—coronary artery disease	3.44e-06	4.12e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling by GPCR—CXCL8—coronary artery disease	3.42e-06	4.11e-05	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism—GSTP1—coronary artery disease	3.41e-06	4.09e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—PPP2CA—coronary artery disease	3.41e-06	4.09e-05	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism—PPARGC1A—coronary artery disease	3.38e-06	4.05e-05	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—FGF2—coronary artery disease	3.37e-06	4.05e-05	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism—HMOX1—coronary artery disease	3.36e-06	4.03e-05	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—HIF1A—coronary artery disease	3.35e-06	4.03e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—PRKCD—coronary artery disease	3.34e-06	4.01e-05	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—AGT—coronary artery disease	3.34e-06	4.01e-05	CbGpPWpGaD
Doxazosin—ABCB1—Metabolism—GSTP1—coronary artery disease	3.33e-06	3.99e-05	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—NOS3—coronary artery disease	3.33e-06	3.99e-05	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—KIT—coronary artery disease	3.33e-06	3.99e-05	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism—CAT—coronary artery disease	3.32e-06	3.98e-05	CbGpPWpGaD
Doxazosin—ABCB1—Metabolism—PPARGC1A—coronary artery disease	3.3e-06	3.96e-05	CbGpPWpGaD
Doxazosin—ABCB1—Metabolism—HMOX1—coronary artery disease	3.28e-06	3.94e-05	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—LEP—coronary artery disease	3.27e-06	3.93e-05	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—APOE—coronary artery disease	3.27e-06	3.93e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—HTR2A—coronary artery disease	3.27e-06	3.93e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—C3—coronary artery disease	3.27e-06	3.92e-05	CbGpPWpGaD
Doxazosin—ABCB1—Metabolism—CAT—coronary artery disease	3.24e-06	3.89e-05	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—APOA1—coronary artery disease	3.24e-06	3.88e-05	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—JAK2—coronary artery disease	3.23e-06	3.88e-05	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism—APOB—coronary artery disease	3.22e-06	3.86e-05	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—KDR—coronary artery disease	3.21e-06	3.85e-05	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—GSK3B—coronary artery disease	3.19e-06	3.83e-05	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—MAPK14—coronary artery disease	3.19e-06	3.82e-05	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling by GPCR—PIK3CA—coronary artery disease	3.17e-06	3.8e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Metabolism—PPARG—coronary artery disease	3.17e-06	3.8e-05	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—POMC—coronary artery disease	3.17e-06	3.8e-05	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—CREB1—coronary artery disease	3.17e-06	3.8e-05	CbGpPWpGaD
Doxazosin—ABCB1—Metabolism—APOB—coronary artery disease	3.14e-06	3.77e-05	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—GSTP1—coronary artery disease	3.14e-06	3.76e-05	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism—GSTM1—coronary artery disease	3.13e-06	3.76e-05	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—ESR1—coronary artery disease	3.13e-06	3.75e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Metabolism—POMC—coronary artery disease	3.13e-06	3.75e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—HIF1A—coronary artery disease	3.12e-06	3.74e-05	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—PPARGC1A—coronary artery disease	3.11e-06	3.73e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—AGT—coronary artery disease	3.11e-06	3.73e-05	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—CCL2—coronary artery disease	3.1e-06	3.72e-05	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—HMOX1—coronary artery disease	3.09e-06	3.71e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Hemostasis—AKT1—coronary artery disease	3.09e-06	3.71e-05	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—IL6R—coronary artery disease	3.09e-06	3.71e-05	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—F2—coronary artery disease	3.09e-06	3.71e-05	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—FN1—coronary artery disease	3.09e-06	3.71e-05	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—IL6ST—coronary artery disease	3.08e-06	3.69e-05	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism—LPL—coronary artery disease	3.08e-06	3.69e-05	CbGpPWpGaD
Doxazosin—ABCB1—Metabolism—GSTM1—coronary artery disease	3.06e-06	3.67e-05	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—CAT—coronary artery disease	3.05e-06	3.66e-05	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—NFKBIA—coronary artery disease	3.05e-06	3.66e-05	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—IGF1—coronary artery disease	3.05e-06	3.66e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—APOE—coronary artery disease	3.04e-06	3.65e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—LEP—coronary artery disease	3.04e-06	3.65e-05	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling by GPCR—MAPK1—coronary artery disease	3.03e-06	3.64e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—APOA1—coronary artery disease	3.01e-06	3.61e-05	CbGpPWpGaD
Doxazosin—ABCB1—Metabolism—LPL—coronary artery disease	3e-06	3.6e-05	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism—GPX1—coronary artery disease	3e-06	3.6e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—KDR—coronary artery disease	2.98e-06	3.58e-05	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—APOB—coronary artery disease	2.96e-06	3.55e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—MAPK14—coronary artery disease	2.96e-06	3.55e-05	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—KIT—coronary artery disease	2.96e-06	3.55e-05	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—CXCL8—coronary artery disease	2.95e-06	3.54e-05	CbGpPWpGaD
Doxazosin—ABCB1—Metabolism—GPX1—coronary artery disease	2.93e-06	3.51e-05	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism—CD36—coronary artery disease	2.92e-06	3.51e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—ESR1—coronary artery disease	2.9e-06	3.49e-05	CbGpPWpGaD
Doxazosin—ADRA1B—GPCR downstream signaling—PIK3CA—coronary artery disease	2.9e-06	3.48e-05	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—SERPINE1—coronary artery disease	2.89e-06	3.47e-05	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism—PPP2CA—coronary artery disease	2.89e-06	3.46e-05	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—GSTM1—coronary artery disease	2.88e-06	3.46e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—FN1—coronary artery disease	2.87e-06	3.44e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—F2—coronary artery disease	2.87e-06	3.44e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—IL6ST—coronary artery disease	2.86e-06	3.43e-05	CbGpPWpGaD
Doxazosin—ABCB1—Metabolism—CD36—coronary artery disease	2.85e-06	3.42e-05	CbGpPWpGaD
Doxazosin—ADRA1D—GPCR downstream signaling—AKT1—coronary artery disease	2.85e-06	3.42e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Metabolism—ALB—coronary artery disease	2.85e-06	3.42e-05	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—GSK3B—coronary artery disease	2.84e-06	3.4e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—NFKBIA—coronary artery disease	2.84e-06	3.4e-05	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—LPL—coronary artery disease	2.83e-06	3.39e-05	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—CASP3—coronary artery disease	2.82e-06	3.39e-05	CbGpPWpGaD
Doxazosin—ABCB1—Metabolism—PPP2CA—coronary artery disease	2.82e-06	3.38e-05	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—POMC—coronary artery disease	2.81e-06	3.38e-05	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—CREB1—coronary artery disease	2.81e-06	3.38e-05	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling by GPCR—IL6—coronary artery disease	2.81e-06	3.37e-05	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—FGF2—coronary artery disease	2.8e-06	3.36e-05	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism—MTHFR—coronary artery disease	2.77e-06	3.32e-05	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—NOS3—coronary artery disease	2.76e-06	3.31e-05	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—GPX1—coronary artery disease	2.76e-06	3.31e-05	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—CCL2—coronary artery disease	2.75e-06	3.3e-05	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—CCND1—coronary artery disease	2.75e-06	3.3e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—KIT—coronary artery disease	2.75e-06	3.29e-05	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—IL6R—coronary artery disease	2.74e-06	3.29e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Metabolism—NOS3—coronary artery disease	2.73e-06	3.27e-05	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—IGF1—coronary artery disease	2.71e-06	3.25e-05	CbGpPWpGaD
Doxazosin—ABCB1—Metabolism—MTHFR—coronary artery disease	2.7e-06	3.24e-05	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling by GPCR—MAPK1—coronary artery disease	2.69e-06	3.23e-05	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—CD36—coronary artery disease	2.69e-06	3.23e-05	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—JAK2—coronary artery disease	2.68e-06	3.22e-05	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—MMP9—coronary artery disease	2.67e-06	3.2e-05	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—PPP2CA—coronary artery disease	2.65e-06	3.18e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—GSK3B—coronary artery disease	2.63e-06	3.16e-05	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism—AGT—coronary artery disease	2.63e-06	3.16e-05	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling by GPCR—PIK3CA—coronary artery disease	2.63e-06	3.16e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—POMC—coronary artery disease	2.61e-06	3.14e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—CREB1—coronary artery disease	2.61e-06	3.14e-05	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling by GPCR—AKT1—coronary artery disease	2.59e-06	3.11e-05	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism—APOE—coronary artery disease	2.58e-06	3.09e-05	CbGpPWpGaD
Doxazosin—ADRA1A—GPCR downstream signaling—PIK3CA—coronary artery disease	2.57e-06	3.09e-05	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—SERPINE1—coronary artery disease	2.57e-06	3.08e-05	CbGpPWpGaD
Doxazosin—ABCB1—Metabolism—AGT—coronary artery disease	2.57e-06	3.08e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—CCL2—coronary artery disease	2.56e-06	3.07e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—IL6R—coronary artery disease	2.55e-06	3.06e-05	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism—APOA1—coronary artery disease	2.55e-06	3.06e-05	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—MTHFR—coronary artery disease	2.55e-06	3.06e-05	CbGpPWpGaD
Doxazosin—ABCB1—Metabolism—APOE—coronary artery disease	2.52e-06	3.02e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—IGF1—coronary artery disease	2.51e-06	3.02e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling by GPCR—MAPK1—coronary artery disease	2.5e-06	3e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Metabolism—PTGS2—coronary artery disease	2.49e-06	2.99e-05	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—FGF2—coronary artery disease	2.49e-06	2.98e-05	CbGpPWpGaD
Doxazosin—ABCB1—Metabolism—APOA1—coronary artery disease	2.49e-06	2.98e-05	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—NOS3—coronary artery disease	2.45e-06	2.94e-05	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—CXCL8—coronary artery disease	2.45e-06	2.94e-05	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—coronary artery disease	2.44e-06	2.93e-05	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—AGT—coronary artery disease	2.42e-06	2.9e-05	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—VEGFA—coronary artery disease	2.4e-06	2.88e-05	CbGpPWpGaD
Doxazosin—ADRA2A—GPCR downstream signaling—PIK3CA—coronary artery disease	2.39e-06	2.87e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—SERPINE1—coronary artery disease	2.39e-06	2.86e-05	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—JAK2—coronary artery disease	2.38e-06	2.86e-05	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—APOE—coronary artery disease	2.37e-06	2.85e-05	CbGpPWpGaD
Doxazosin—ADRA1B—GPCR downstream signaling—AKT1—coronary artery disease	2.37e-06	2.84e-05	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—CASP3—coronary artery disease	2.34e-06	2.81e-05	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—APOA1—coronary artery disease	2.34e-06	2.81e-05	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling by GPCR—PIK3CA—coronary artery disease	2.34e-06	2.8e-05	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling by GPCR—IL6—coronary artery disease	2.33e-06	2.8e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—FGF2—coronary artery disease	2.31e-06	2.77e-05	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—CCND1—coronary artery disease	2.28e-06	2.74e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—NOS3—coronary artery disease	2.28e-06	2.74e-05	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism—PPARG—coronary artery disease	2.25e-06	2.69e-05	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—MMP9—coronary artery disease	2.22e-06	2.66e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—JAK2—coronary artery disease	2.22e-06	2.66e-05	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism—POMC—coronary artery disease	2.21e-06	2.66e-05	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—TGFB1—coronary artery disease	2.2e-06	2.64e-05	CbGpPWpGaD
Doxazosin—ABCB1—Metabolism—PPARG—coronary artery disease	2.19e-06	2.63e-05	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—CXCL8—coronary artery disease	2.18e-06	2.61e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling by GPCR—PIK3CA—coronary artery disease	2.17e-06	2.61e-05	CbGpPWpGaD
Doxazosin—ABCB1—Metabolism—POMC—coronary artery disease	2.16e-06	2.59e-05	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—MAPK1—coronary artery disease	2.16e-06	2.59e-05	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling by GPCR—AKT1—coronary artery disease	2.15e-06	2.58e-05	CbGpPWpGaD
Doxazosin—ADRA1A—GPCR downstream signaling—AKT1—coronary artery disease	2.1e-06	2.52e-05	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—CASP3—coronary artery disease	2.08e-06	2.5e-05	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling by GPCR—IL6—coronary artery disease	2.07e-06	2.48e-05	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—PPARG—coronary artery disease	2.07e-06	2.48e-05	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—POMC—coronary artery disease	2.04e-06	2.44e-05	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—CCND1—coronary artery disease	2.03e-06	2.43e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—CXCL8—coronary artery disease	2.02e-06	2.43e-05	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism—ALB—coronary artery disease	2.02e-06	2.42e-05	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—VEGFA—coronary artery disease	1.99e-06	2.39e-05	CbGpPWpGaD
Doxazosin—ABCB1—Metabolism—ALB—coronary artery disease	1.97e-06	2.36e-05	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—MMP9—coronary artery disease	1.97e-06	2.36e-05	CbGpPWpGaD
Doxazosin—ADRA2A—GPCR downstream signaling—AKT1—coronary artery disease	1.95e-06	2.34e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—CASP3—coronary artery disease	1.94e-06	2.32e-05	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism—NOS3—coronary artery disease	1.93e-06	2.32e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling by GPCR—IL6—coronary artery disease	1.92e-06	2.31e-05	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling by GPCR—AKT1—coronary artery disease	1.91e-06	2.29e-05	CbGpPWpGaD
Doxazosin—ABCB1—Metabolism—NOS3—coronary artery disease	1.88e-06	2.26e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—CCND1—coronary artery disease	1.88e-06	2.26e-05	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—PIK3CA—coronary artery disease	1.87e-06	2.25e-05	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—ALB—coronary artery disease	1.86e-06	2.23e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—MMP9—coronary artery disease	1.83e-06	2.19e-05	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—TGFB1—coronary artery disease	1.83e-06	2.19e-05	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—MAPK1—coronary artery disease	1.79e-06	2.15e-05	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—NOS3—coronary artery disease	1.78e-06	2.13e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling by GPCR—AKT1—coronary artery disease	1.77e-06	2.13e-05	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—VEGFA—coronary artery disease	1.77e-06	2.12e-05	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism—PTGS2—coronary artery disease	1.77e-06	2.12e-05	CbGpPWpGaD
Doxazosin—ABCB1—Metabolism—PTGS2—coronary artery disease	1.72e-06	2.07e-05	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—IL6—coronary artery disease	1.66e-06	1.99e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—VEGFA—coronary artery disease	1.64e-06	1.97e-05	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—PTGS2—coronary artery disease	1.62e-06	1.95e-05	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—TGFB1—coronary artery disease	1.62e-06	1.95e-05	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—MAPK1—coronary artery disease	1.59e-06	1.91e-05	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—PIK3CA—coronary artery disease	1.55e-06	1.86e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Metabolism—PIK3CA—coronary artery disease	1.53e-06	1.84e-05	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—AKT1—coronary artery disease	1.53e-06	1.84e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—TGFB1—coronary artery disease	1.51e-06	1.81e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—MAPK1—coronary artery disease	1.48e-06	1.77e-05	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—PIK3CA—coronary artery disease	1.38e-06	1.66e-05	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—IL6—coronary artery disease	1.38e-06	1.65e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—PIK3CA—coronary artery disease	1.28e-06	1.54e-05	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—AKT1—coronary artery disease	1.27e-06	1.52e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Metabolism—AKT1—coronary artery disease	1.25e-06	1.5e-05	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—IL6—coronary artery disease	1.22e-06	1.47e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—IL6—coronary artery disease	1.14e-06	1.36e-05	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—AKT1—coronary artery disease	1.13e-06	1.35e-05	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism—PIK3CA—coronary artery disease	1.09e-06	1.3e-05	CbGpPWpGaD
Doxazosin—ABCB1—Metabolism—PIK3CA—coronary artery disease	1.06e-06	1.27e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—AKT1—coronary artery disease	1.05e-06	1.26e-05	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—PIK3CA—coronary artery disease	9.99e-07	1.2e-05	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism—AKT1—coronary artery disease	8.88e-07	1.07e-05	CbGpPWpGaD
Doxazosin—ABCB1—Metabolism—AKT1—coronary artery disease	8.66e-07	1.04e-05	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—AKT1—coronary artery disease	8.16e-07	9.8e-06	CbGpPWpGaD
